2 months ago
NEO
AnalystsDavid WestenbergDavid Westenberg's Stock Forecasts
AnalystsDavid Westenberg
Analyst Ranking
Top 1%
#30 out of 5254 analysts
Average Return
+94.33%
Win Rate
55%70 out of 127
Risk vs Reward
Poor
Good
David Westenberg's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exact Sciences CorpEXAS | +4,459.01% | $40.91 | $1,865.09 | 2025-08-11 - 2026-03-24 | Strong Buy |
Exact Sciences CorpEXAS | +3,044.12% | $59.32 | $1,865.09 | 2025-10-08 - 2026-03-24 | Strong Buy |
Exact Sciences CorpEXAS | +2,663.10% | $67.50 | $1,865.09 | 2025-11-11 - 2026-03-24 | Strong Buy |
Natera IncNTRA | +204.75% | $42.33 | $129.00 | 2023-10-16 - 2024-10-15 | Strong Buy |
Natera IncNTRA | +133.26% | $47.08 | $109.82 | 2023-05-30 - 2024-05-29 | Strong Buy |
David Westenberg Analyst Color
Get additional color on David Westenberg's coverage of popular stocks
3 months ago
ELAN
5 months ago
NTRA
5 months ago
EXAS
6 months ago
GH
6 months ago
ADPT
7 months ago
WGS
8 months ago
NTRA
8 months ago
ADPT
8 months ago
WGS
a year ago
GH
a year ago
TEM
a year ago
NTRA
a year ago
ADPT
2 years ago
EXAS
2 years ago
GH
2 years ago
NTRA
2 years ago
NTRA
2 years ago
ZTS
4 years ago
NVTAQ
4 years ago
CTKB
David Westenberg's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Caris Life Sciences IncCAI | 1 | Hold | $21.00 | -0.71% | Initiates Coverage On | 10 days ago |
Grail IncGRAL | 1 | Hold | $54.00 | +4.43% | Initiates Coverage On | 10 days ago |
Genedx Holdings CorpWGS | 4 | Strong Buy | $130.00 | +97.09% | Maintains | 2 months ago |
Guardant Health IncGH | 11 | Strong Buy | $130.00 | +43.87% | Maintains | 2 months ago |
Neogenomics IncNEO | 11 | Strong Buy | $13.00 | +55.69% | Maintains | 2 months ago |
Labcorp Holdings IncLH | 5 | Hold | $300.00 | +10.83% | Maintains | 2 months ago |
Idexx Laboratories IncIDXX | 9 | Hold | $750.00 | +27.28% | Maintains | 2 months ago |
Illumina IncILMN | 16 | Strong Buy | $170.00 | +26.39% | Maintains | 2 months ago |
Elanco Animal Health IncELAN | 11 | Strong Buy | $30.00 | +26.69% | Upgrades | 3 months ago |
Zoetis IncZTS | 13 | Hold | $135.00 | +10.31% | Downgrades | 3 months ago |
Neogen CorpNEOG | 14 | Hold | $10.00 | +5.15% | Reiterates | 3 months ago |
Billiontoone IncBLLN | 1 | Strong Buy | $150.00 | +88.85% | Initiates Coverage On | 5 months ago |
10x Genomics IncTXG | 3 | Hold | $19.00 | -27.15% | Maintains | 5 months ago |
Tempus Ai IncTEM | 6 | Hold | $80.00 | +43.19% | Maintains | 5 months ago |
Pacific Biosciences Of California IncPACB | 10 | Hold | $2.00 | +18.34% | Maintains | 5 months ago |
Natera IncNTRA | 17 | Strong Buy | $230.00 | +10.36% | Maintains | 5 months ago |
Fulgent Genetics IncFLGT | 10 | Hold | $30.00 | +84.50% | Maintains | 5 months ago |
Exact Sciences CorpEXAS | 13 | Strong Buy | $80.00 | -95.71% | Maintains | 5 months ago |
Cytek Biosciences IncCTKB | 10 | Strong Buy | $7.50 | +62.69% | Maintains | 5 months ago |
Quest Diagnostics IncDGX | 8 | Hold | $200.00 | +2.55% | Maintains | 6 months ago |
Adaptive Biotechnologies CorpADPT | 12 | Strong Buy | $20.00 | +38.22% | Maintains | 6 months ago |
Akoya Biosciences IncAKYA | 8 | Hold | $1.65 | N/A | Maintains | a year ago |
Insight Molecular Diagnostics IncIMDX | 7 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Invitae CorpNVTAQ | 5 | Strong Sell | $0.30 | N/A | Maintains | 2 years ago |
Heska CorpHSKA | 6 | Strong Buy | $165.00 | N/A | Maintains | 3 years ago |
Covetrus IncCVET | 1 | Strong Buy | $30.00 | N/A | Upgrades | 5 years ago |
Petiq IncPETQ | 1 | Strong Buy | $44.00 | N/A | Maintains | 6 years ago |
Quidelortho CorpQDEL | 1 | Buy | N/A | N/A | Upgrades | 8 years ago |
Trupanion IncTRUP | 1 | Hold | N/A | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.